Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

DPH 1,380.00 -3.00 (-0.22%)
price chart
Has Dechra kept up the good work? Investors await Friday's trading update
At the end of September Cantor Fitzgerald analyst Brian White said it had been “another good year” for veterinary drug firm Dechra Pharmaceuticals (LON:DPH), following its annual results. Friday is expected to bring a trading update for the current ...
Recent Broker Updates On Dechra Pharmaceuticals (LON:DPH)  NewsDen
Dechra Pharmaceuticals plc (DPH) Price Target Raised to GBX 1412
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) had its price objective raised by N+1 Singer from GBX 1,350 ($16.45) to GBX 1,412 ($17.21) in a note issued to investors on Friday.
Rating Change: N+1 Singer Keeps Dechra Pharmaceuticals PLC (LON:DPH) As Buy ...  Thorold News
Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after ...
Pharmaceutical giants Dechra Pharmaceuticals (LSE: DPH) and GlaxoSmithKline (LSE: GSK) took divergent paths in Monday morning business despite both releasing positive updates.
Dechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for ...
Dechra Pharmaceuticals PLC (LSE: symbol DPH) announces the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in the US, based in Portland, Maine.
Portland-based pet medicine company Putney acquired by British firm for $200 ...  Press Herald
Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc 'buys' after ...
Also reporting today was Dechra Pharmaceuticals (LSE: DPH). Its trading in the most recent full year was strong, with revenue rising by 21%.
Dechra� Pharmaceuticals PLC: Trading Update & Notice of 2016 Annual Results  PR Newswire (press release)
Dechra Pharmaceuticals plc (DPH) Receives Consensus Recommendation of "Buy ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the company.
Dechra Pharmaceuticals plc 12.5% Potential Upside Indicated by Cantor Fitzgerald
Dechra Pharmaceuticals plc using EPIC/TICKER code LON:DPH has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Cantor Fitzgerald.
Cantor Fitzgerald Indicates Potential 13.29% Increase In Shares Of Dechra ...  Fiscal Standard
GW Pharmaceuticals PLC- ADR 51% Potential Upside Now Implied by Cantor ...  Cosumnes Connection (subscription)
Dechra Pharmaceuticals plc (DPH) Receives GBX 1296.43 Consensus Target Price ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have been given an average rating of “Buy” by the eight analysts that are currently covering the firm.
Dechra Pharmaceuticals (LON:DPH) Broker Roundup  The De Soto Edge
Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?
Pet medicines mammoth Dechra Pharmaceuticals (LSE: DPH) cheered the market with terrific half-year numbers in Monday business, propelling the stock 8% higher from the end of last week.
Dechra� Pharmaceuticals PLC (Dechra or the Group) : Trading Update
The Board of Dechra Pharmaceuticals PLC (LSE:DPH), issues the following unaudited Trading Update ahead of the Group's half-year financial results for the period ended 31 December 2015, which will be announced on Monday, 22 February 2016.